![[Campus Biotech] Swiss Medical Group acquires CoreMedica Europe](https://republic-of-innovation.ch/wordpress/wp-content/uploads/2020/10/Coremedica-630x162.jpg)
Swiss Medical Group (SMG) has acquired CoreMedica Europe for an undisclosed amount to expand its footprint in Europe and the rest of the world.
Campus Biotech-based CoreMedica Europe specialises in a mass spectrometry technology platform, which identifies a patient’s nutritional profile, using dried blood. The company also focus on the analysis of a range of biomarkers and offers personalised recommendations, using patented technology in areas such as immunity, nutrition, sports and anti-aging. Recently, CoreMedica Europe combined Covid-19 screening test and immunity profile with its available home self-collection kit to enable customers to collect their blood at home for coronavirus diagnosis.